|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/14/21 Cell MedX Corp. 10-Q 8/31/21 50:2.2M Empire Stock Transf… Inc |
Document/Exhibit Description Pages Size
1: 10-Q Cell Medx Corp. - Form 10-Q SEC Filing HTML 388K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 18K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 18K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 15K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 15K
12: R1 Document and Entity Information HTML 65K
13: R2 Condensed Consolidated Balance Sheets HTML 94K
14: R3 Condensed Consolidated Balance Sheets - HTML 22K
Parenthetical
15: R4 Condensed Consolidated Statements of Operations HTML 79K
16: R5 Condensed Consolidated Statement of Stockholders' HTML 64K
Deficit
17: R6 Condensed Consolidated Statements of Cash Flows HTML 80K
18: R7 Organization and Nature of Operations HTML 22K
19: R8 Related Party Transactions Disclosure HTML 33K
20: R9 Other Current Assets Disclosure HTML 17K
21: R10 Equipment Disclosure HTML 24K
22: R11 Revenue Disclosure HTML 22K
23: R12 Notes and Advances Payable Disclosure HTML 39K
24: R13 Share Capital Disclosure HTML 44K
25: R14 Related Party Transactions Disclosure: Schedule of HTML 24K
Amounts Due to Related Parties (Tables)
26: R15 Related Party Transactions Disclosure: Schedule of HTML 24K
Transactions with Related Parties (Tables)
27: R16 Equipment Disclosure: Change in book value of the HTML 23K
equipment (Tables)
28: R17 Revenue Disclosure: Schedule of Revenue and HTML 22K
Associated Costs (Tables)
29: R18 Notes and Advances Payable Disclosure: Schedule of HTML 30K
Short-term Loans and Advances Outstanding (Tables)
30: R19 Share Capital Disclosure: Schedule of Stock Option HTML 25K
Activity (Tables)
31: R20 Share Capital Disclosure: Schedule of Stock HTML 19K
Options Outstanding (Tables)
32: R21 Share Capital Disclosure: Schedule of Warrant HTML 26K
Activity (Tables)
33: R22 Share Capital Disclosure: Schedule of Warrant HTML 22K
Details (Tables)
34: R23 Organization and Nature of Operations (Details) HTML 19K
35: R24 Related Party Transactions Disclosure: Schedule of HTML 34K
Amounts Due to Related Parties (Details)
36: R25 Related Party Transactions Disclosure: Schedule of HTML 26K
Transactions with Related Parties (Details)
37: R26 Other Current Assets Disclosure (Details) HTML 20K
38: R27 Equipment Disclosure: Change in book value of the HTML 26K
equipment (Details)
39: R28 Revenue Disclosure: Schedule of Revenue and HTML 38K
Associated Costs (Details)
40: R29 Notes and Advances Payable Disclosure: Schedule of HTML 32K
Short-term Loans and Advances Outstanding
(Details)
41: R30 Notes and Advances Payable Disclosure (Details) HTML 46K
42: R31 Share Capital Disclosure (Details) HTML 31K
43: R32 Share Capital Disclosure: Schedule of Stock Option HTML 30K
Activity (Details)
44: R33 Share Capital Disclosure: Schedule of Stock HTML 20K
Options Outstanding (Details)
45: R34 Share Capital Disclosure: Schedule of Warrant HTML 24K
Activity (Details)
46: R35 Share Capital Disclosure: Schedule of Warrant HTML 24K
Details (Details)
48: XML IDEA XML File -- Filing Summary XML 86K
11: XML XBRL Instance -- cmxc-20210831_htm XML 498K
47: EXCEL IDEA Workbook of Financial Reports XLSX 40K
6: EX-101.CAL XBRL Calculations -- cmxc-20210831_cal XML 55K
7: EX-101.DEF XBRL Definitions -- cmxc-20210831_def XML 197K
8: EX-101.LAB XBRL Labels -- cmxc-20210831_lab XML 387K
9: EX-101.PRE XBRL Presentations -- cmxc-20210831_pre XML 331K
10: EX-101.SCH XBRL Schema -- cmxc-20210831 XSD 129K
49: JSON XBRL Instance as JSON Data -- MetaLinks 160± 225K
50: ZIP XBRL Zipped Folder -- 0001393905-21-000459-xbrl Zip 72K
| Certification |
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Cell MedX Corp. (the “Company”) on Form 10-Q for the period ending August 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:
(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: October 14, 2021
/s/ Yanika Silina
Chief Financial Officer
(Principal Accounting Officer)
C:
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/14/21 | 424B3 | ||
| For Period end: | 8/31/21 | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 10/14/21 Cell MedX Corp. 424B3 1:365K Empire Stock Transf… Inc |